12:00 AM
 | 
Nov 23, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

XL147: Interim Phase I data

Interim data from an ongoing, open-label, dose-escalation, U.S. Phase I trial in 15 evaluable patients showed that oral XL147 in combination with paclitaxel and carboplatin produced 4 partial responses in patients previously treated with a platinum-containing chemotherapy...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >